Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection

Abstract

infection, local T cells expressed high levels of mucosal homing and tissue residency markers. Our data show that pulmonary MTBVAC administration has the potential to enhance its efficacy and justifies further exploration of mucosal vaccination strategies in preclinical efficacy studies.